↓ Skip to main content

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

Overview of attention for article published in Investigational New Drugs, February 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#27 of 1,197)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
patent
25 patents

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
49 Mendeley
Title
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel
Published in
Investigational New Drugs, February 2011
DOI 10.1007/s10637-011-9642-4
Pubmed ID
Authors

Michael Millward, Paul Mainwaring, Alain Mita, Kristine Federico, G. K. Lloyd, Natasha Reddinger, Steffan Nawrocki, Monica Mita, Matthew A. Spear

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 27%
Researcher 10 20%
Professor > Associate Professor 5 10%
Student > Bachelor 4 8%
Student > Doctoral Student 3 6%
Other 7 14%
Unknown 7 14%
Readers by discipline Count As %
Chemistry 9 18%
Biochemistry, Genetics and Molecular Biology 7 14%
Medicine and Dentistry 6 12%
Agricultural and Biological Sciences 6 12%
Nursing and Health Professions 2 4%
Other 8 16%
Unknown 11 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#1,495,479
of 23,572,442 outputs
Outputs from Investigational New Drugs
#27
of 1,197 outputs
Outputs of similar age
#5,904
of 107,587 outputs
Outputs of similar age from Investigational New Drugs
#1
of 11 outputs
Altmetric has tracked 23,572,442 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,197 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,587 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.